China Health Supplements: Q1 2024 Market Intelligence

Executive Summary

China's online health supplements market exceeded CN¥ 25 billion in Q1 2024, rising +2.0% YoY. The headline growth rate understates the structural story: Douyin (抖音) is now the primary engine of incremental sales, posting +91.9% GMV growth in the eye health sub-segment alone, while Tmall (天猫) and JD.com (京东) face mounting pressure from this newer entrant. Sub-segment performance is sharply divergent — oral beauty, historically the market's largest category, lost momentum, while eye health (+20.5%), sports nutrition (+23.0%), liver health (+13.0%), and throat health (+82.2%) all posted meaningful growth. Social media discussion data confirms the shift: liver health discussions grew +50.9% YoY and eye health +40.5%, while immunity-related conversation collapsed -53.2%. For brands operating in or entering the health supplements space, Q1 2024 marks a structural inflection point — from a category defined by broad immunity products to one where targeted, scenario-anchored health solutions command both consumer attention and commercial premium.

China's Macro Context: A Selective Consumer Recovery

China's macro economy continued a gradual recovery path entering Q1 2024. Per capita disposable income and consumer expenditure trended upward, though recovery remained uneven across categories. Travel and tourism rebounded strongly — the Qingming 2024 holiday recorded 119 million domestic tourist trips (+11.5% vs. 2019) and CN¥ 53.95 billion in tourism spending (+12.7% vs. 2019). Consumer confidence, however, remained below prior-year levels, reflecting the persistence of post-pandemic caution and continued real estate sector drag.

Online retail's share of total retail consumption reached 24.2% — approaching what analysts describe as a near-term ceiling. Category performance in Q1 2024 diverged sharply: tobacco and alcohol led at +12.5% YoY, communications equipment at +13.2%, and food and beverages at +9.6%, while cultural and office supplies contracted -8.0%. Health supplements' +2.0% gain placed it within the broader Chinese and Western medicine category, which grew +5.8% — a respectable, if unspectacular, showing for a market shaped by shifting consumer health priorities.

Online Health Supplements: CN¥ 25 Billion and a Platform Power Shift

The CN¥ 25 billion total market figure masks the most consequential trend in Q1 2024: the redistribution of growth across platforms. Tmall and JD.com retain the largest absolute market share, with Swisse (斯维诗) and By-Health (汤臣倍健) leading both platforms respectively, but their growth rates lag the Douyin channel by a wide margin.

Douyin's top-five brand ranking tells a different story to the traditional platforms:

Q1 2024 Health Supplements Top Brands by Platform

On Tmall and JD.com, the top brands are established, internationally recognised names with strong clinical heritage and brand trust. On Douyin, the top-five is dominated by newer, more aggressively-positioned players — Renhe (仁和), WonderLab, Five Female Doctors (五个女博士) — whose products are built for social virality, taste appeal, and live-streaming commerce conversion rather than clinical prestige. Douyin is no longer optional for health supplement growth; brands that treat it as an incremental channel risk ceding structural share in the fastest-growing platform segment.

Sub-Segment Performance: Where the Market Is Actually Growing

The most strategically significant finding in Q1 2024 is the divergence between high-growth sub-segments and the stalling oral beauty category. Oral beauty — historically the market's largest functional segment by GMV — saw declining momentum, while five sub-categories posted robust growth:

Q1 2024 Health Supplements Sub-Segment: GMV vs. Growth Rate

Eye Health: Gummies, Douyin, and the Renhe Blueprint

Eye health is the standout breakout sub-category of Q1 2024. The market posted +20.5% YoY GMV growth overall, with Douyin contributing +91.9% platform-level growth driven primarily by one product: Renhe's Blueberry Lutein Ester Gummy.

The dosage form shift within eye health products is dramatic. Gummies grew +89.7% YoY, capsules a modest +3.4%, tablets collapsed -36.9%, and sachets effectively exited the category at -99.6%. This is not a cyclical fluctuation — it reflects a durable shift in format preferences among younger consumers who treat daily health products as part of their lifestyle routine rather than a medical intervention.

The Renhe playbook is instructive for any brand entering a health supplement sub-segment via Douyin: position for a specific, sympathetic consumer (parents buying for children); price at an accessible mass-market level (CN¥ 29.9 per bottle vs. Swisse's CN¥ 369); formulate for the format preference (gummies with clean-label claims); and seed through contextually relevant KOL communities (family and mother-and-baby creators). The result in Q1 2024 was +501.6% YoY sales growth and a +19.6 percentage point market share gain within the eye health segment.

From an ingredient standpoint, beta-carotene posted the strongest growth rate (+95%) among eye health ingredients, while lutein ester (+42%) and blueberry extract (+35%) remain the core commercially dominant inputs. Astaxanthin (-5%) is the only declining ingredient, suggesting ingredient-level preferences are still concentrated in the established, evidence-backed cluster.

Liver Health: Scenario-Driven Content and the Spring Seasonal Tailwind

Liver health grew approximately +13.0% YoY in Q1 2024, with social media discussion volume up +50.9% — the fastest YoY discussion growth of any tracked health topic. The structural catalyst is seasonal: in traditional Chinese medicine, spring is the liver's season, and Chinese consumers have deeply internalised this framework into purchasing behaviour. Q1 encompasses the Qingming holiday — a high-traffic moment for liver health content and category purchasing.

Analysis of liver health social media discussion reveals a scenario-first structure: 56.9% of posts centre on usage contexts (late nights, 39.1%; social drinking, 32.5%; overtime work, 18.4%), while 31.3% address efficacy, and only 11.8% discuss ingredients. This discussion architecture has a direct commercial implication: brands anchoring content in these relatable scenarios — rather than clinical liver function claims — generate higher organic engagement and stronger KOL seeding traction.

Milk thistle (奶蓟草) dominates ingredient-level discussion at 62.7%, underpinned by the combined marketing weight of Swisse and By-Health. Hovenia dulcis (+25% growth) is the fastest-growing ingredient, driven by Beijing Tongrentang and Huatuo Guoyao. Traditional Chinese medicine ingredients — angelica and astragalus — are declining as consumers shift preference toward internationally recognised, evidence-backed alternatives.

Swisse demonstrates best-in-class category building in liver health through a three-channel approach: upgrading its flagship milk thistle tablet to a second-generation formulation with added choline and broccoli seed; concentrating celebrity endorsement spend (Dilraba Dilmurat, Zhou Ye) and iQIYI variety show sponsorship (Riding the Wind 2024, 乘风2024); and dramatising the late-night usage scenario through an offline "Full-Power Party" experiential event. Each element reinforces the same core consumer insight: liver health is not a medical concern — it is an everyday performance and lifestyle issue.

Social Media as the Primary Discovery and Purchase Funnel

Across all health supplement sub-categories, social media has become the dominant channel for consumer discovery, trust-building, and purchase conversion. The Q1 2024 social media discussion data makes the directional shift explicit: eye health (+40.5%), anti-aging (+43.0%), liver health (+50.9%), and skin health (+19.6%) are accelerating, while immunity enhancement (-53.2%) and sports health (-37.2%) are contracting sharply from COVID-era peaks.

These discussion volume movements are leading indicators of commercial category performance. The correlation between rising social media discussion and Q1 2024 GMV growth across eye health and liver health is direct and lagged by only one to two quarters, making social media monitoring an essential forward-looking input for brands assessing category entry and portfolio investment decisions.

The most effective content strategies in Q1 2024 are scenario-based rather than claim-based. For liver health, late-night and social drinking scenarios dominate. For eye health, screen fatigue, myopia, and study pressure resonate most with the core working-age and parent buyer. Brands that educate consumers on ingredient science — the mechanism behind lutein ester's bioavailability advantage, or milk thistle's silymarin content — are building the trust infrastructure that converts social engagement into repeat purchase.

Future Outlook: Four Forces Shaping China's Health Supplements Market

Four converging forces will define the market's trajectory over the next 12–24 months.

Compound and multi-functional formulations displace single-ingredient products. Consumer ingredient literacy is rising, and products that address two or more health needs through scientifically-validated compound blends will command both premium pricing and stronger repurchase. Probiotics, collagen, and whey protein represent the commercial sweet spot: large absolute scale, high growth, and broad consumer familiarity.

Snackification accelerates across sub-categories. Gummies and functional drinks are displacing tablets and capsules not only in eye health but across the broader supplements market. Brands that have not yet developed snack-format line extensions face a product relevance gap, particularly with consumers under 35 years old who drive Douyin's health supplement growth.

Douyin becomes a first-tier channel, not an experiment. The platform gap between Douyin's growth trajectory and Tmall's will widen in 2024 and 2025. Brands without live-streaming commerce infrastructure, KOL seeding programmes aligned to health sub-categories, and content teams capable of producing scenario-driven short video at scale will find Douyin increasingly difficult to compete on.

Targeting replaces breadth as the organising principle of brand strategy. The consumer shift from broad immunity products to specific, condition-adjacent health management — eye health for screen fatigue, liver health for urban lifestyle, sports nutrition for fitness participation — is durable and demographically-driven by an aging population and a younger cohort with high health awareness. Brands that define clear category ownership in one or two targeted sub-segments, rather than maintaining a broad-line portfolio across immunity and oral beauty, will generate more durable brand equity and more efficient marketing ROI.

Key Takeaways

• China's online health supplements market exceeded CN¥ 25 billion in Q1 2024, up +2.0% YoY — modest headline growth that masks a significant platform power shift toward Douyin (抖音).
• Eye health (+20.5%) and sports nutrition (+23.0%) lead sub-segment growth; oral beauty and immunity enhancement are both in negative territory, signalling structural category maturation.
• Gummy-format eye health products grew +89.7% YoY; tablets fell -36.9% and sachets -99.6% — the snackification of health supplements is a durable format trend, not a fad.
• Liver health social media discussion grew +50.9% YoY, driven by scenario-first content (late nights, drinking culture, overtime); milk thistle captures 62.7% of ingredient-level discussion.
• Renhe's Blueberry Lutein Ester Gummy (CN¥ 29.9/bottle) achieved +501.6% YoY sales growth via Douyin seeding — the platform-native, accessible-price, snack-format playbook is the defining growth model for 2024.

About the Data

This analysis draws on Moojing Market Intelligence (魔镜洞察) data tracking China's online health supplements market in Q1 2024. Market data covers Tmall (天猫), Taobao (淘宝), JD.com (京东), and Douyin (抖音), measuring GMV, brand market share, and sub-segment performance. Social media data is sourced from Douyin, Xiaohongshu (小红书), and Weibo. All figures are in Chinese Yuan (CN¥) and reflect online channels only.